MDA is trading 4.4% down at $40.27 as investors rotate capital into the newly listed SpaceX following a period of strong performance.
- Selling pressure is attributed to investors using former space proxy names like MDA as a source of funds for the SpaceX listing.
- No company-specific negative catalysts have emerged; the firm's fundamentals and recent deal activity remain intact.
- The decline represents a partial retracement of recent gains driven by significant contract wins and acquisition news.